Reassessing recombinant human activated protein C for sepsis: Time for a new randomized controlled trial

被引：38

作者：

Eichacker, PQ ^{[1
]}

Danner, RL ^{[1
]}

Suffredini, AF ^{[1
]}

Cui, XZ ^{[1
]}

Natanson, C ^{[1
]}

机构：

[1] NIH, Crit Care Med Dept, Warren C Magnuson Clin Ctr, Bethesda, MD 20892 USA

来源：

CRITICAL CARE MEDICINE | 2005年 / 33卷 / 10期

关键词：

recombinant human activated protein C; ENHANCE; PROWESS;

D O I：

10.1097/01.CCM.0000183002.26587.FF

中图分类号：

R4 [临床医学];

学科分类号：

1002 [临床医学]; 100602 [中西医结合临床];

摘要：

引用

页码：2426 / 2428

页数：3

共 11 条

[1]

Efficacy and safety of recombinant human activated protein C for severe sepsis. [J].

Bernard, GR ;

Vincent, JL ;

Laterre, P ;

LaRosa, SP ;

Dhainaut, JF ;

Lopez-Rodriguez, A ;

Steingrub, JS ;

Garber, GE ;

Helterbrand, JD ;

Ely, EW ;

Fisher, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) :699-709

[2]

Substantiating the concerns about recombinant human activated protein C use in sepsis [J].

Deans, KJ ;

Minneci, PC ;

Banks, SM ;

Natanson, C ;

Eichacker, PQ .

CRITICAL CARE MEDICINE, 2004, 32 (12) :2542-2543

[3]

Recombinant human activated protein C in sepsis: Inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials [J].

Eichacker, PQ ;

Natanson, C .

CRITICAL CARE MEDICINE, 2003, 31 (01) :S94-S96

[4]

EISENBERG P, IMPORTANT DRUG WARNI

[5]

EISENBERG P, DISCONTINUATION STUD

[6]

LATERRE F, 2004, 17 ESICM ANN C BERL

[7]

Powers JH, 2005, CHEST, V127, P2298, DOI 10.1378/chest.127.6.2298

[8]

TANZI M, 2004, USE DROTRECOGIN ALFA

[9]

THOMSON PDR, 2003, PHYS DESK REFERENCE, P1875

[10]

Dyotyecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment [J].

Vincent, JL ;

Bernard, GR ;

Beale, R ;

Doig, C ;

Putensen, C ;

Dhainaut, JF ;

Artigas, A ;

Fumagalli, R ;

Macias, W ;

Wright, T ;

Wong, K ;

Sundin, DP ;

Turlo, MA ;

Janes, J .

CRITICAL CARE MEDICINE, 2005, 33 (10) :2266-2277

← 1 2 →